- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x NHE: 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID(Non-covalent)
- 3 x R0S: 4-(5-chloro-2-{[1-(3,4-dimethoxyphenyl)-2-oxo-1,2-dihydro-3H-imidazo[4,5-c]pyridin-3-yl]methyl}-1H-indol-1-yl)butanenitrile(Non-covalent)
R0S.2: 14 residues within 4Å:- Chain A: F.140, T.397, S.398, D.486, F.488
- Chain B: F.137, F.488
- Chain C: F.140, F.488, D.489
- Ligands: SO4.8, R0S.10, SO4.16, R0S.18
15 PLIP interactions:4 interactions with chain C, 8 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: C:F.140, C:F.140, C:F.488, C:D.489, A:F.140, A:F.140, A:F.488, A:F.488, A:F.488, A:F.488, B:F.488
- pi-Stacking: A:F.140, B:F.488, B:F.488
- Halogen bonds: A:T.397
R0S.10: 14 residues within 4Å:- Chain A: F.140, F.488, D.489
- Chain B: F.140, T.397, S.398, D.486, F.488
- Chain C: F.137, F.488
- Ligands: R0S.2, SO4.16, R0S.18, SO4.24
15 PLIP interactions:8 interactions with chain B, 4 interactions with chain A, 3 interactions with chain C- Hydrophobic interactions: B:F.140, B:F.140, B:F.488, B:F.488, B:F.488, B:F.488, A:F.140, A:F.140, A:F.488, A:D.489, C:F.488
- pi-Stacking: B:F.140, C:F.488, C:F.488
- Halogen bonds: B:T.397
R0S.18: 14 residues within 4Å:- Chain A: F.137, F.488
- Chain B: F.140, F.488, D.489
- Chain C: F.140, T.397, S.398, D.486, F.488
- Ligands: R0S.2, SO4.8, R0S.10, SO4.24
15 PLIP interactions:4 interactions with chain B, 3 interactions with chain A, 8 interactions with chain C- Hydrophobic interactions: B:F.140, B:F.140, B:F.488, B:D.489, A:F.488, C:F.140, C:F.140, C:F.488, C:F.488, C:F.488, C:F.488
- pi-Stacking: A:F.488, A:F.488, C:F.140
- Halogen bonds: C:T.397
- 6 x CL: CHLORIDE ION(Non-functional Binders)
CL.3: 2 residues within 4Å:- Chain A: K.315, W.341
Ligand excluded by PLIPCL.4: 2 residues within 4Å:- Chain A: N.460, Q.462
Ligand excluded by PLIPCL.11: 2 residues within 4Å:- Chain B: K.315, W.341
Ligand excluded by PLIPCL.12: 2 residues within 4Å:- Chain B: N.460, Q.462
Ligand excluded by PLIPCL.19: 2 residues within 4Å:- Chain C: K.315, W.341
Ligand excluded by PLIPCL.20: 2 residues within 4Å:- Chain C: N.460, Q.462
Ligand excluded by PLIP- 12 x SO4: SULFATE ION(Non-functional Binders)
SO4.5: 4 residues within 4Å:- Chain A: L.273, N.276, N.277, R.364
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:N.276, A:N.277
- Salt bridges: A:R.364
SO4.6: 5 residues within 4Å:- Chain A: S.443, K.445, G.464, K.465, S.466
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:S.443, A:S.466, A:S.466
- Water bridges: A:G.464
- Salt bridges: A:K.445
SO4.7: 4 residues within 4Å:- Chain A: N.444, K.445, G.446, K.461
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:N.444, A:G.446
- Salt bridges: A:K.461
SO4.8: 6 residues within 4Å:- Chain A: F.137, L.138, G.139, Q.354
- Ligands: R0S.2, R0S.18
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:F.137, A:F.137, A:G.139, A:Q.354
SO4.13: 4 residues within 4Å:- Chain B: L.273, N.276, N.277, R.364
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:N.276, B:N.277
- Salt bridges: B:R.364
SO4.14: 5 residues within 4Å:- Chain B: S.443, K.445, G.464, K.465, S.466
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:S.443, B:S.466, B:S.466
- Water bridges: B:G.464
- Salt bridges: B:K.445
SO4.15: 4 residues within 4Å:- Chain B: N.444, K.445, G.446, K.461
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:N.444, B:G.446
- Salt bridges: B:K.461
SO4.16: 6 residues within 4Å:- Chain B: F.137, L.138, G.139, Q.354
- Ligands: R0S.2, R0S.10
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:F.137, B:F.137, B:G.139, B:Q.354
SO4.21: 4 residues within 4Å:- Chain C: L.273, N.276, N.277, R.364
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:N.276, C:N.277
- Salt bridges: C:R.364
SO4.22: 5 residues within 4Å:- Chain C: S.443, K.445, G.464, K.465, S.466
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:S.443, C:S.466, C:S.466
- Water bridges: C:G.464
- Salt bridges: C:K.445
SO4.23: 4 residues within 4Å:- Chain C: N.444, K.445, G.446, K.461
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:N.444, C:G.446
- Salt bridges: C:K.461
SO4.24: 6 residues within 4Å:- Chain C: F.137, L.138, G.139, Q.354
- Ligands: R0S.10, R0S.18
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:F.137, C:G.139, C:Q.354
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Vendeville, S. et al., Discovery of 3-({5-Chloro-1-[3-(methylsulfonyl)propyl]-1H-indol-2-yl}methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one (JNJ-53718678), a Potent and Orally Bioavailable Fusion Inhibitor of Respiratory Syncytial Virus. J.Med.Chem. (2020)
- Release Date
- 2020-05-27
- Peptides
- Prefusion RSV F (DS-Cav1): ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
FB
FC
F
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x NHE: 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID(Non-covalent)
- 3 x R0S: 4-(5-chloro-2-{[1-(3,4-dimethoxyphenyl)-2-oxo-1,2-dihydro-3H-imidazo[4,5-c]pyridin-3-yl]methyl}-1H-indol-1-yl)butanenitrile(Non-covalent)
- 6 x CL: CHLORIDE ION(Non-functional Binders)
- 12 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Vendeville, S. et al., Discovery of 3-({5-Chloro-1-[3-(methylsulfonyl)propyl]-1H-indol-2-yl}methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one (JNJ-53718678), a Potent and Orally Bioavailable Fusion Inhibitor of Respiratory Syncytial Virus. J.Med.Chem. (2020)
- Release Date
- 2020-05-27
- Peptides
- Prefusion RSV F (DS-Cav1): ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
FB
FC
F